Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Safest stablecoins in 2026 balance resilience, reserve quality, and regulatory alignment. This primer outlines evaluation criteria.
15,169 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
A growing cohort of Bitcoin veterans is converting crypto gains into hardened security, from armored vehicles to unde...
AI-driven data centers are fueling a power supercycle, pushing on-site generation and turbocharging turbine prices. G...
Markets confront a rebalanced risk outlook as Iran signals it may push for nuclear concessions to survive. Investors ...
As 2026 brings higher IRMAA thresholds, retirees near the line must plan for steeper Medicare costs. This report expl...
After 15 years of bullish calls on banks, a veteran analyst pivots to private equity and other alternatives, downgrad...
Coinbase posts a fee-driven growth model with a robust moat, while MicroStrategy grapples with bitcoin volatility. Th...
As markets stabilize in 2026, a growing argument centers on placing the Vanguard Mid-Cap ETF (VO) inside a Roth IRA t...
Fiserv announced the resignation of fiserv president dhivya suryadevara after less than a month in the role, with int...
The U.S. government is on a heavy borrowing pace in fiscal 2026, with monthly borrowing around $155 billion and inter...
As of early 2026, Social Security provides about 40% of typical workers' pre-retirement income, leaving a sizable gap...
Broadcom is tightening its AI-driven growth narrative with a year-end price target and brisk AI silicon momentum, set...